← back to search

Enwei Xu

Shanxi Provincial Cancer Hospital ·
Area of research
Molecular Biology · Surgery
Research interest
Research interests include Esophageal Cancer Research and Treatment, Cancer-related gene regulation, Cancer Genomics and Diagnostics, and Pancreatic and Hepatic Oncology Research.
h-index
18
citations
1,933
works
54
NIH funding
primary concept
Medicine
email

Recent publications

Multi-omics analysis reveals immunosuppression in oesophageal squamous cell carcinoma induced by creatine accumulation and HK3 deficiency
Genome Medicine 2025cited by 7position: middledoi
Immune-tumor interaction dictates spatially directed evolution of esophageal squamous cell carcinoma
National Science Review 2024cited by 18position: middledoi
The splicing factor SF3B1 confers ferroptosis resistance and promotes lung adenocarcinoma progression via upregulation of SLC7A11
Cancer Gene Therapy 2024cited by 10position: middledoi
The glycogene alterations and potential effects in esophageal squamous cell carcinoma
Cellular and Molecular Life Sciences 2024cited by 5position: middledoi
MBIP promotes ESCC metastasis by activating MAPK pathway
Cellular Signalling 2024cited by 2position: middledoi
TSTA3 overexpression promotes malignant characteristics in LUSC by regulating LAMP2-mediated autophagy and tumor microenvironment
Cancer Cell International 2023cited by 9position: middledoi
Integrated multi-omics profiling yields a clinically relevant molecular classification for esophageal squamous cell carcinoma
Cancer Cell 2022cited by 170position: middledoi
Extracellular vesicles mediated proinflammatory macrophage phenotype induced by radiotherapy in cervical cancer
BMC Cancer 2022cited by 23position: middledoi
Subclassifying triple-negative breast cancers and its potential clinical utility
Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin 2022cited by 9position: middledoi
Two cases report of secretory carcinoma of the salivary gland in the lung: one primary and one metastatic after many years
Gland Surgery 2022cited by 9position: middledoi
Author Correction: Whole-genome sequencing of 508 patients identifies key molecular features associated with poor prognosis in esophageal squamous cell carcinoma
Cell Research 2022cited by 6position: middledoi
CDCA7 Facilitates Tumor Progression by Directly Regulating CCNA2 Expression in Esophageal Squamous Cell Carcinoma
Frontiers in Oncology 2021cited by 20position: middledoi
Identification of miRNA-34a and miRNA-155 as prognostic markers for mantle cell lymphoma
Journal of International Medical Research 2021cited by 6position: middledoi
Whole-genome sequencing of 508 patients identifies key molecular features associated with poor prognosis in esophageal squamous cell carcinoma
Cell Research 2020cited by 317position: middledoi
A standardized pathological proposal for evaluating microvascular invasion of hepatocellular carcinoma: a multicenter study by LCPGC
Hepatology International 2020cited by 119position: middledoi
Decreased ZNF750 promotes angiogenesis in a paracrine manner via activating DANCR/miR-4707-3p/FOXC2 axis in esophageal squamous cell carcinoma
Cell Death and Disease 2020cited by 50position: middledoi
Novel ESCC-related gene ZNF750 as potential Prognostic biomarker and inhibits Epithelial-Mesenchymal Transition through directly depressing SNAI1 promoter in ESCC
Theranostics 2020cited by 37position: middledoi
Clinical-Pathologic Analysis of Breast Cancer With PIK3CA Mutations in Chinese Women
Technology in Cancer Research & Treatment 2020cited by 13position: middledoi
Corrigendum to “FAT1 prevents epithelial mesenchymal transition (EMT) via MAPK/ERK signaling pathway in esophageal squamous cell cancer” [Canc. Lett. 397 (2017) 83–93]
Cancer Letters 2020cited by 7position: middledoi
Author Correction: Multi-region sequencing unveils novel actionable targets and spatial heterogeneity in esophageal squamous cell carcinoma
Nature Communications 2020cited by 6position: middledoi
Multi-region sequencing unveils novel actionable targets and spatial heterogeneity in esophageal squamous cell carcinoma
Nature Communications 2019cited by 149position: middledoi
EP300 as an oncogene correlates with poor prognosis in esophageal squamous carcinoma
Journal of Cancer 2019cited by 51position: middledoi
Hormone Receptor and Human Epidermal Growth Factor Receptor 2 Detection in Invasive Breast Carcinoma: A Retrospective Study of 12,467 Patients From 19 Chinese Representative Clinical Centers
Clinical Breast Cancer 2019cited by 39position: middledoi
Screening of MSI detection loci and their heterogeneity in East Asian colorectal cancer patients
Cancer Medicine 2019cited by 37position: middledoi
High TSTA3 Expression as a Candidate Biomarker for Poor Prognosis of Patients With ESCC
Technology in Cancer Research & Treatment 2018cited by 16position: middledoi
FAT1 prevents epithelial mesenchymal transition (EMT) via MAPK/ERK signaling pathway in esophageal squamous cell cancer
Cancer Letters 2017cited by 104position: middledoi
Whole-Genome Sequencing Reveals Diverse Models of Structural Variations in Esophageal Squamous Cell Carcinoma
The American Journal of Human Genetics 2016cited by 146position: middledoi
Genomic analyses reveal FAM84B and the NOTCH pathway are associated with the progression of esophageal squamous cell carcinoma
GigaScience 2016cited by 87position: middledoi
Genomic Analyses Reveal Mutational Signatures and Frequently Altered Genes in Esophageal Squamous Cell Carcinoma
The American Journal of Human Genetics 2015cited by 342position: middledoi
Mutually exclusive mutations in<i>NOTCH1</i>and<i>PIK3CA</i>associated with clinical prognosis and chemotherapy responses of esophageal squamous cell carcinoma in China
Oncotarget 2015cited by 26position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Yanfeng Xi · Hangzhou Cancer Hospital7 papers (2019–2024)Yuanfang Zhai · Ministry of Education of the People's Republic of China6 papers (2020–2025)Yongping Cui · Shanxi Medical University5 papers (2020–2024)Heyang Cui · Shanxi Medical University5 papers (2020–2025)Ting Yan · Shanxi Medical University4 papers (2020–2024)Pengzhou Kong · Shanxi Medical University4 papers (2020–2025)Yikun Cheng · University of California, Berkeley4 papers (2020–2025)Binbin Zou · Shanxi Medical University4 papers (2020–2025)Xuefei Feng · Shanxi Medical University4 papers (2023–2025)Ling Zhang · Harbin Medical University4 papers (2020–2025)Yanlin Guo · Shanxi Medical University4 papers (2023–2025)Jian Yang · Tianjin University of Traditional Chinese Medicine3 papers (2020–2024)Yanghui Bi · Shanxi Medical University3 papers (2020–2021)Yanchun Ma · Shanxi Medical University3 papers (2020–2024)Caixia Cheng · Shanxi Medical University3 papers (2020–2021)Yongsheng Meng · Shanxi Medical University3 papers (2021–2025)Yanlong Hao · Shanxi Medical University2 papers (2023–2024)Ruifang Sun · Xi'an Jiaotong University2 papers (2024–2025)Bin Song · Shanghai Medical College of Fudan University2 papers (2020–2020)Xiaoqin Xu · Nanjing Agricultural University2 papers (2020–2020)